Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses.

Données et ressources

Info additionnelle

Champ Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis – Publication de l’ICH E9(R1): Les estimés et l’analyse de sensibilité dans les essais cliniques
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published 2020-07-17 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["orientation E9(R1)", "estimation appropriée", "essai clinique", "analyses de sensibilité", "conseil international pour l'harmonisation", "exigences techniques", "produits pharmaceutiques à usage humain"], "en": ["guidance E9(R1)", "appropriate estimand", "clinical trial", "sensitivity analyses", "international council for-harmonisation", "technical requirements", "pharmaceuticals for human-use"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source